Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome

Qian Zhang, Elena J. Orlando, Hong Y. Wang, Agata M. Bogusz, Xiaobin Liu, Simon F. Lacey, Honore T. Strauser, Selene Nunez-Cruz, Reza Nejati, Paul Zhang, Sarah Brooks, Christopher Watt, J. Joseph Melenhorst, Carl H. June, Stephen J. Schuster, Mariusz A. Wasik

Blood (2020) 136 (17): 1980–1983.

https://doi.org/10.1182/blood.2020005123

Published: 2020

Includes: Supplemental data

Journal Articles

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Engraftment and Antitumor Responses Against Mantle Cell Lymphoma

Marco Ruella, MD, Saad S Kenderian, MD, Olga Shestova, PhD, Joseph A. Fraietta, PhD, Sohail Qayyum, MD, Qian Zhang, MD PhD, Marcela V. Maus, MDPhD, Xiaobin Liu, PhD, Selene Nunez-Cruz, PhD, Michael Klichinsky, PharmD, Omkar Uday Kawalekar, MS, BS, Michael C. Milone, MD PhD, Simon F. Lacey, PhD BSc, Anthony Mato, MD, Stephen J. Schuster, MD, Michael Kalos, PhD, Carl H. June, MD, Saar I Gill, MBBS, PhD, Mariusz A. Wasik, MD

Blood (2015) 126 (23): 704.

https://doi.org/10.1182/blood.V126.23.704.704

Published: 2015

Journal Articles

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

Qian Zhang, HongYi Wang, Kanchan Kantekure, Jennifer C. Paterson, Xiaobin Liu, Andras Schaffer, Chrystal Paulos, Michael C. Milone, Niels Odum, Suzanne Turner, Teresa Marafioti, Mariusz A. Wasik

Blood (2011) 118 (11): 3062–3071.

https://doi.org/10.1182/blood-2011-01-332916

Published: 2011

Includes: Supplemental data

Journal Articles

IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4 + T lymphocytes

Michal Marzec, Xiaobin Liu, Monika Kasprzycka, Agnieszka Witkiewicz, Puthiyaveettil N. Raghunath, Mouna El-Salem, Erle Robertson, Niels Odum, Mariusz A. Wasik

Blood (2008) 111 (4): 2181–2189.

https://doi.org/10.1182/blood-2007-06-095182

Published: 2008

Journal Articles

Stat5a Is Epigenetically Silenced by Oncogenic Tyrosine Kinase NPM/ALK and Acts as Tumor Suppressor by Reciprocally Inhibiting Expression of NPM/ALK.

Qian Zhang, MD, PhD, Hong Yi Wang, PhD, XiaoBin Liu, Ms, Mariusz A. Wasik, MD

Blood (2007) 110 (11): 4170.

https://doi.org/10.1182/blood.V110.11.4170.4170

Published: 2007

NARROW

Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Engraftment and Antitumor Responses Against Mantle Cell Lymphoma

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4 + T lymphocytes

Stat5a Is Epigenetically Silenced by Oncogenic Tyrosine Kinase NPM/ALK and Acts as Tumor Suppressor by Reciprocally Inhibiting Expression of NPM/ALK.

Email alerts

ASH Publications

American Society of Hematology

Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Engraftment and Antitumor Responses Against Mantle Cell Lymphoma

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4 + T lymphocytes

Stat5a Is Epigenetically Silenced by Oncogenic Tyrosine Kinase NPM/ALK and Acts as Tumor Suppressor by Reciprocally Inhibiting Expression of NPM/ALK.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only